Manage stand orders
Select Option

Icosagen Cell Factory OÜ

Eerika tee 1 Õssu Kula, 61713 Kambja Vald
Estonia
Telephone +372 737 7054
Fax +372 737 7077
info@icosagen.com

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Contact

Eveliis Koppel

Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.01  Immuno assay testing
  • 03  Diagnostic tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.04  Other equipment for immunochemistry and immunology

Other equipment for immunochemistry and immunology

  • 03  Diagnostic tests
  • 03.07  Other diagnostics

Other diagnostics

Our products

Product category: Immuno assay testing

Serological COVID-19 ELISA kit

Icosagen Covid-19 ELISA kit provides a rapid and easy method for semiquantitative determination of both IgG and IgM antibodies against SARS-CoV-2 (2019-nCoV) Spike and Nucleocapsid proteins in human sera and plasma.

APPLICATION
The kit includes reagents necessary to analyze SARS-CoV-2 specific antibodies in up to 46 samples using one kit. ELISA titers can be determined in 23 serum or plasma samples.

More Less

Product category: Immuno assay testing

Human CDNF ELISA kit

Kit description:
High sensitivity: Limit of detection 1-8 pg/mL
Can be used to detect small quantities of CDNF starting from 15 pg/mL
Assay range 15 pg/mL to 960 pg/mL
High affinity of the CDNF antibodies (antibodies raised against full length recombinant CDNF)
The entire test procedure can be performed at room temperature
Short testing time (2 hours)

The kit has been developed based on Icosagen’s unique CDNF antibodies, which are raised against full-length recombinant protein expressed in mammalian cell culture. As is the case with many of the other antibodies in Icosagen's portfolio, they have high affinity and high specificity (no cross reactivity to other nerve growth factors).

More Less

Product category: Immuno assay testing

Monoclonal antibodies against SARS-CoV-2 Nucleocapsid protein

Icosagen has developed an antibody pair against SARS-CoV-2 Nucleocapsid protein with subpicomolar affinities. As nucleocapsid protein is the most abundant, it is a preferred diagnostic target when developing an antigen assay. We already see that this pair can detect the nucleocapsid protein even as low concentration as 6 pg/ml. Further studies with clinical samples from COVID-19 patients will start soon to detect the virus infection.

You can find more information from the attached PDF file.

More Less

About us

Company portrait

Icosagen discovers premium antibodies with great diversity, affinity, and developability, as well as producing high-quality recombinant proteins/antibodies for its partner companies. Success of our scientific team stems from the unique combination of proprietary technologies, and the company’s extensive competence related to the protein biochemistry, molecular cloning and cell line engineering.
Icosagen is putting 20 years of experience in pharma field into developing relevant diagnostics catalogue.

Company data

Number of employees 50-99
Area of business Diagnostics

Company information as a PDF file